Evidence map›Paper›PMID 31011900›Full record

ArticleAnnals of surgical oncology2019

Population-Based Study on Risk Factors for Tumor-Positive Resection Margins in Patients with Gastric Cancer.

Leonie R van der Werf, Charlotte Cords, Ivo Arntz, Eric J T Belt, Ivan M Cherepanin, Peter-Paul L O Coene, Erwin van der Harst, Joos Heisterkamp, Barbara S Langenhoff, Bas Lamme and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Annals of surgical oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Indocyanine green fluorescence-guided proximal margin identification in laparoscopic distal gastrectomy: a randomized clinical trial.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2026
    Trial
  4. Article
  5. R1 Resection in Gastric Cancer: Marker of Tumor Biology Rather Than Surgical Failure.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Sex differences in tumor characteristics, treatment, and outcomes of gastric and esophageal cancer surgery: nationwide cohort data from the Dutch Upper GI Cancer Audit.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2022
    Article
  15. Article
  16. Short- and long-term oncological outcomes of totally laparoscopic gastrectomy versus laparoscopy-assisted gastrectomy for clinical stage I gastric cancer.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 1 country.

Leonie R van der WerfDepartment of Surgery, Erasmus University Medical Centre Rotterdam, Rotterdam, The Netherlands. l.r.vdwerf@gmail.com.ORCID http://orcid.org/0000-0002-6880-6612
Charlotte CordsDepartment of Surgery, Erasmus University Medical Centre Rotterdam, Rotterdam, The Netherlands.
Ivo ArntzDepartment of Surgery, Bravis Hospital, Roosendaal, The Netherlands.
Eric J T BeltDepartment of Surgery, Albert Schweitzer Hospital, Dordrecht, The Netherlands.
Ivan M CherepaninDepartment of Surgery, Bravis Hospital, Roosendaal, The Netherlands.
Peter-Paul L O CoeneDepartment of Surgery, Maasstad Hospital, Rotterdam, The Netherlands.
Erwin van der HarstDepartment of Surgery, Maasstad Hospital, Rotterdam, The Netherlands.
Joos HeisterkampDepartment of Surgery, Elisabeth Tweesteden Hospital, Tilburg, The Netherlands.
Barbara S LangenhoffDepartment of Surgery, Elisabeth Tweesteden Hospital, Tilburg, The Netherlands.
Bas LammeDepartment of Surgery, Albert Schweitzer Hospital, Dordrecht, The Netherlands.
Mark I van Berge HenegouwenDepartment of Surgery, Cancer Center Amsterdam, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
Sjoerd M LagardeDepartment of Surgery, Erasmus University Medical Centre Rotterdam, Rotterdam, The Netherlands.
Bas P L WijnhovenDepartment of Surgery, Erasmus University Medical Centre Rotterdam, Rotterdam, The Netherlands.
Erasmus University Rotterdam · NLAlbert Schweitzer Ziekenhuis · NLBravis Ziekenhuis · NLElisabeth-TweeSteden Ziekenhuis · NLMaasstad Ziekenhuis · NLErasmus MC · NLUniversity of Amsterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRadical gastrectomy is the cornerstone of the treatment of locally advanced gastric cancer. This study was designed to evaluate factors associated with a tumor-positive resection margin after gastrectomy and to evaluate the influence of hospital volume.

methodsIn this Dutch cohort study, patients with junctional or gastric cancer who underwent curative gastrectomy between 2011 and 2017 were included. The primary outcome was incomplete tumor removal after the operation defined as the microscopic presence of tumor cells at the resection margin. The association of patient and disease characteristics with incomplete tumor removal was tested with multivariable regression analysis. The association of annual hospital volume with incomplete tumor removal was tested and adjusted for the patient- and disease characteristics.

resultsIn total, 2799 patients were included. Incomplete tumor removal was seen in 265 (9.5%) patients. Factors associated with incomplete tumor removal were: tumor located in the entire stomach (odds ratio (OR) [95% confidence interval (CI): 3.38 [1.91-5.96] reference: gastroesophageal junction), cT3, cT4, cTx (1.75 [1.20-2.56], 2.63 [1.47-4.70], 1.60 [1.03-2.48], reference: cT0-2), pN+ (2.73 [1.96-3.80], reference: pN-), and diffuse and unknown histological subtype (3.15 [2.14-4.46] and 2.05 [1.34-3.13], reference: intestinal). Unknown differentiation grade was associated with complete tumor removal (0.50 [0.30-0.83], reference: poor/undifferentiated). Compared with a hospital volume of < 20 resections/year, 20-39, and > 39 resections were associated with lower probability for incomplete tumor removal (OR 0.56 [0.42-0.76] and 0.34 [0.18-0.64]).

conclusionsTumor location, cT, pN, histological subtype, and tumor differentiation are associated with incomplete tumor removal. The association of incomplete tumor removal with an annual hospital volume of < 20 resections may underline the need for further centralization of gastric cancer care in the Netherlands.

Indexed as

Margins of ExcisionAdenocarcinomaAgedCohort StudiesFemaleFollow-Up StudiesGastrectomyHospitals, High-VolumeHospitals, Low-VolumeHumansMaleNetherlandsPrognosisRisk FactorsStomach Neoplasms

Identifiers

PMID31011900
PMCPMC6545177
OpenAlexW2942025786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.